This issue of Thoracic Surgery Clinics, guest edited by Drs. Jyoti Patel and Jessica Donington, is devoted to Advances in Systemic Therapy for Non-Small Cell Lung Cancer. Drs. Patel and Donington have assembled expert authors to review the following topics: Adjuvant and Neoadjuvant Immunotherapy; Combining Immunotherapy with Radiation in Lung Cancer; Adjuvant Chemotherapy; ALK Mutations; Molecular Targets Beyond the Big 3; Advances in Systemic Therapy; Liquid Biopsies in NSCLC; Combining Immunotherapy and Chemotherapy for NSCLC; ROS-1 Mutations; EGFR Mutations; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Erratum - p. xi 8. Preface - p. xiii 9. Current Landscape of Personalized Therapy - p. 121 10. Epidermal Growth Factor Receptor Mutations - p. 127 11. Anaplastic Lymphoma Kinase Mutation–Positive Non–Small Cell Lung Cancer - p. 137 12. ROS1-rearranged Non–small Cell Lung Cancer - p. 147 13. Molecular Targets Beyond the Big 3 - p. 157 14. Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer - p. 165 15. Adjuvant Chemotherapy - p. 179 16. Principles of Immunotherapy in Non-Small Cell Lung Cancer - p. 187 17. Combining Immunotherapy and Chemotherapy for Non–Small Cell Lung Cancer - p. 199 18. Biomarkers for Immunotherapy - p. 207 19. Adjuvant and Neoadjuvant Immunotherapy in Non–small Cell Lung Cancer - p. 215 20. Combining Immunotherapy with Radiation Therapy in Non–Small Cell Lung Cancer - p. 221
This issue of Thoracic Surgery Clinics, guest edited by Drs. Jyoti Patel and Jessica Donington, is devoted to Advances in Systemic Therapy for Non-Small Cell Lung Cancer. Drs. Patel and Donington have assembled expert authors to review the following topics: Adjuvant and Neoadjuvant Immunotherapy; Combining Immunotherapy with Radiation in Lung Cancer; Adjuvant Chemotherapy; ALK Mutations; Molecular Targets Beyond the Big 3; Advances in Systemic Therapy; Liquid Biopsies in NSCLC; Combining Immunotherapy and Chemotherapy for NSCLC; ROS-1 Mutations; EGFR Mutations; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. ix 7. Erratum - p. xi 8. Preface - p. xiii 9. Current Landscape of Personalized Therapy - p. 121 10. Epidermal Growth Factor Receptor Mutations - p. 127 11. Anaplastic Lymphoma Kinase Mutation–Positive Non–Small Cell Lung Cancer - p. 137 12. ROS1-rearranged Non–small Cell Lung Cancer - p. 147 13. Molecular Targets Beyond the Big 3 - p. 157 14. Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer - p. 165 15. Adjuvant Chemotherapy - p. 179 16. Principles of Immunotherapy in Non-Small Cell Lung Cancer - p. 187 17. Combining Immunotherapy and Chemotherapy for Non–Small Cell Lung Cancer - p. 199 18. Biomarkers for Immunotherapy - p. 207 19. Adjuvant and Neoadjuvant Immunotherapy in Non–small Cell Lung Cancer - p. 215 20. Combining Immunotherapy with Radiation Therapy in Non–Small Cell Lung Cancer - p. 221
